Gene: ELMO1
Official Full Name: engulfment and cell motility 1provided by HGNC
Gene Summary: This gene encodes a member of the engulfment and cell motility protein family. These proteins interact with dedicator of cytokinesis proteins to promote phagocytosis and cell migration. Increased expression of this gene and dedicator of cytokinesis 1 may promote glioma cell invasion, and single nucleotide polymorphisms in this gene may be associated with diabetic nephropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32670 | ELMO1 Knockout cell line (HEK293) | Human | ELMO1 | 1:3~1:6 | Negative | Online Inquiry |
KO32671 | ELMO1 Knockout cell line (A549) | Human | ELMO1 | 1:3~1:4 | Negative | Online Inquiry |
ELMO1 Gene Knockout Cell Lines offer a revolutionary approach for studying the essential roles of ELMO1 in cellular processes such as phagocytosis, cell migration, and immune response modulation. ELMO1 (Engulfment and Cell Motility 1) is a vital guanine nucleotide exchange factor that activates the Rac signaling pathway, driving actin cytoskeleton rearrangements. The knockout of ELMO1 in these engineered cell lines allows researchers to dissect the functional consequences of its absence and further understand complex biological mechanisms.
The key mechanism of ELMO1 Gene Knockout Cell Lines involves the precise inactivation of the ELMO1 gene through CRISPR-Cas9 technology, leading to a significant reduction in ELMO1 protein expression. This alteration enables studies that elucidate the gene's contribution to various cellular mechanisms, including the modulation of inflammation and cancer metastasis, thus providing critical insights into pathological conditions.
The scientific importance of these cell lines extends to diverse research and clinical applications, ranging from elucidating the underlying pathways in diseases such as cancer and autoimmune disorders to assessing therapeutic strategies targeting ELMO1. These cell lines are invaluable for high-throughput screening of potential modulators of cell motility and immune cell function.
Unlike traditional methods that rely on pharmacological inhibitors or transient expression systems, ELMO1 Gene Knockout Cell Lines offer a stable and consistent experimental platform, eliminating variability associated with off-target effects. Additionally, these knockout lines can be employed in a variety of cell types, promoting versatility in experimental design.
For researchers and clinicians dedicated to understanding the interactions of immune cells and their tumor microenvironments, ELMO1 Gene Knockout Cell Lines provide a powerful tool for advancing research. Our company specializes in the development and production of innovative biological products, ensuring that each cell line is rigorously tested for quality and reproducibility. With our expertise, we are committed to supporting the scientific community in uncovering new therapeutic strategies and advancing biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.